(1)
Kaushal, K.; Thummar, V.; Mehta, P. Real-World Evaluation of Trastuzumab Emtansine Biosimilar in Early-Stage HER2-Positive Breast Cancer: Results from a Single-Center Retrospective Study in India: Real-World Outcomes of T-DM1 Biosimilar. Arch Breast Cancer 2026, 13, 182-189.